Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions
Top Cited Papers
Open Access
- 14 October 2015
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 66 (21), 2329-2338
- https://doi.org/10.1016/j.jacc.2015.09.063
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Biotronik
This publication has 29 references indexed in Scilit:
- A single stent strategy in patients with lifestyle limiting claudication: 3‐year results from the Durability II trialCatheterization and Cardiovascular Interventions, 2015
- Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal LesionsJournal of the American College of Cardiology, 2013
- Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal DiseaseCirculation: Cardiovascular Interventions, 2011
- Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal ArteryCirculation: Cardiovascular Interventions, 2010
- Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesionsCatheterization and Cardiovascular Interventions, 2009
- Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial diseaseCatheterization and Cardiovascular Interventions, 2007
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)Journal of Vascular Surgery, 2007
- Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral ArteryNew England Journal of Medicine, 2006
- Long-Segment SFA Stenting—The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent FracturesJournal of Endovascular Therapy, 2005
- Prevalence and clinical impact of stent fractures after femoropopliteal stentingJournal of the American College of Cardiology, 2005